Organic Chemistry TRIZ Cases

Fluoropolyether-substituted aryl pnictogens provide corrosion and oxidation inhibition in perfluoropolyether fluids.

Hydrolyze dianhydrides to tetraacids with inorganic acid, filter metal halide impurities, and recover purified dianhydride with less than 50 ppm metal content.

Replacing carbohydrates with benzamidazoles improves bioavailability and binding strength to overcome weak specificity in cancer treatment.

Alkylene oxide modification of dipentaerythritol acrylate lowers viscosity and crystallinity in reactive compositions.

Novel spirobifluorene derivatives replace aromatic amines in organic electroluminescence devices to balance charge transport and reduce drive voltage.

Quinoline-based ligands resolve limited efficacy and specificity of existing inhibitors by targeting CDK-2 to treat cancer and inflammation.

Linking quaternary ammonium ions through aromatic rings reduces toxicity while maintaining efficacy against drug-resistant bacterial infections.

Formula I compounds inhibit oxidative degradation in elastomers, extending protection duration at exposed surfaces where conventional additives fail.

Fused indole-pyrrole azamacrocycle host balances hole and electron transport to resolve internal quantum efficiency versus device lifetime trade-offs.

Heteroaromatic compounds inhibit ASCT2 transporters, restricting glutamine uptake to prevent cancer cell proliferation across multiple subtypes.

Customizable heterocyclic amide molecules generate distinct terahertz resonances to solve the lack of detectable anti-counterfeiting tags.

Novel piperazine-piperidine compounds inhibit hepatitis C virus replication, reducing treatment duration and side effects compared to interferon therapies.

Cyclic monothiocarbonate replaces hazardous isocyanates in polymer synthesis, eliminating moisture sensitivity while maintaining mechanical strength.

Cyclic sulfate and aromatic additives form a passivation film on the negative electrode surface to reduce battery resistance.

Colchicine derivatives modify aromatic rings to target beta-VI tubulin, reducing side effects while maintaining anti-inflammatory efficacy.

Novel N-arylcarboxamide derivatives selectively target the orexin receptor type 1 to treat impulse control deficits without sedative side effects.

A fluorine atom-containing mercapto compound forms a micelle-like structure to enhance affinity with fluorine-based materials.

Tetronic acid ester substitution removes complex anhydrous intermediate steps, boosting yield and purity.

Fluoro-naphthyl compounds bind the M1 allosteric site to boost acetylcholine affinity, resolving selectivity issues and reducing adverse effects.

Novel indolocarbazole-terphenyl compounds enhance charge transport in organic electroluminescent devices.

Synthesizes N-substituted vinylidene compounds from carbonyl precursors using paraformaldehyde in a single reaction step.

Thioflavine S and primuline derivatives inhibit hepatitis C virus helicase activity, addressing viral resistance to existing protease inhibitors.

Fluorene-substituted heterocyclic compounds improve molecular stability to reduce driving voltage and extend device lifespan.

Replacing toxic thallium reagents with alkali hydroxide simplifies the process and improves industrial viability for prostaglandin production.

A one-step catalytic process converts gamma-butyrolactone and monomethylamine into NMP using a Bronsted acidic support.

Irradiating organic semiconductor films with specific light wavelengths activates n-dopant reagents to form conductive layers.

Synthesizing influenza replication inhibitors using palladium catalysts to generate compounds with broad antiviral activity.

Substituted oxazole and thiazole carboxamide derivatives resolve poor oral bioavailability by optimizing molecular parameters to enhance VR1 receptor affinity.

Selective thienyl aminopyrimidine compounds inhibit NUAK2 to block YAP/TAZ localization, reducing neutropenia risks in cancer treatment.

A viologen compound in an electrochromic layer prevents electrolyte degradation from UV irradiation, maintaining contrast ratio over time.

A roflumilast prodrug derivative modifies the benzamide nitrogen to boost water solubility and skin permeability.

A fluorene-based compound with amine derivatives optimizes hole transfer and electron blocking in organic light emitting devices.

Fused bicyclic FXR modulators lower triglycerides and non-HDL cholesterol, addressing inadequate treatment efficacy in hyperlipidemia.

Incorporating formaldehyde into urea feedstock during pyrolysis to produce melamine with enhanced brightness and whiteness.

A 6-membered uracil isostere compound inhibits dUTPase enzyme activity.

ERbeta-selective estrogenic compounds modulate receptor activity to treat menopausal symptoms without increasing breast cancer risk.

Replacing anthracene skeletons with naphthalene cores reduces molecular size, improving solubility and infiltratability into ultrafine wiring patterns.

Fluorinated aryl ketone PAGs reduce acid diffusion during post-exposure bake, resolving image blur and improving pattern fidelity in EUV lithography.

Formula I compounds inhibit PIKfyve kinase to induce cytoplasmic vacuolization and cell death, overcoming treatment resistance in various cancers.

A heterocyclic compound with specific aryl groups lowers operating voltage in organic light emitting devices.

Flow cytometry quantifies thrombus DNA and GPVI concentrations to resolve diagnostic ambiguity in undetermined etiology cases.

An intermediary polyester polyurethane layer prevents nitrocellulose peeling on reptile leather while preserving surface luster.